Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer

Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer

IntroductionTumor microenvironments are immunosuppressive due to progressive accumulation of mutations in cancer cells that can drive expression of a range of inhibitory ligands and cytokines, and recruitment of immunomodulatory cells, including myeloid-derived suppressor cells (MDSC), tumor-associa...

Full description

Bibliographic Details
Main Authors:	Lisa A. Santry, Jacob P. van Vloten, Amanda W. K. AuYeung, Robert C. Mould, Jacob G. E. Yates, Thomas M. McAusland, James J. Petrik, Pierre P. Major, Byram W. Bridle, Sarah K. Wootton
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Microbiology
Subjects:	Newcastle disease virus (NDV) oncolytic virus immunological checkpoint inhibitors anti-CTLA-4 PD-1 PD-L1
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1325558/full

Similar Items

Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
by: Thomas M. McAusland, et al.
Published: (2021-03-01)

Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
by: Bharat Burman, et al.
Published: (2020-11-01)

Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
by: Noemi García-Romero, et al.
Published: (2020-06-01)

The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect
by: Bo-Kyoung Jung, et al.
Published: (2024-01-01)

The antiviral activity of srikaya seed (Annona squamosa L.) ethanolic extract against newcastle disease virus in chicken embryo
by: Nanik Sulistyani, et al.
Published: (2009-05-01)

Cloning of fusion protein gene of Newcastle disease virus into a baculovirus derived bacmid shuttle vector, in order to express it in insect cell line
by: Hashemzadeh MS, et al.
Published: (2015-05-01)

Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
by: Benjamin Gesundheit, et al.
Published: (2020-05-01)

Comparative studies on two tests for detection of avian influenza a virus and Newcastle disease virus in co-infected guinea fowl (Numida meleagris)
by: Iv. Zarkov
Published: (2018-03-01)

The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
by: Upasana Pathak, et al.
Published: (2023-07-01)

Recombinant Newcastle virus rL-RVG inhibits proliferation of human lung adenocarcinoma cell lines
by: ZHANG Zhenzhen, LI Yang, GAO Shengbao, XIA Dexin, YAN Yulan
Published: (2023-10-01)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
by: Shin-Hee Kim, et al.
Published: (2019-03-01)

In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells
by: Ahmed M. Al-Shammari, et al.
Published: (2016-01-01)

Interference chromatography: a novel approach to optimizing chromatographic selectivity and separation performance for virus purification
by: Lisa A. Santry, et al.
Published: (2020-06-01)

Experimental intraocular infection of exotic cockerels with field strain of velogenic Newcastle disease virus in Nigeria
by: Samaila Jonathan Badau, et al.
Published: (2015-12-01)

Phylogenetic and pathotypic characterization of Newcastle disease viruses circulating in South China and transmission in different birds
by: Yinfeng eKang, et al.
Published: (2016-02-01)

Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies
by: Jessica A. Minott, et al.
Published: (2022-11-01)

Clinico-pathological assessment of virulent Newcastle Disease Virus in ducks
by: B. Zahid, et al.
Published: (2022-01-01)

Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
by: Rūta Veinalde, et al.
Published: (2022-03-01)

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
by: Pascal Buijs, et al.
Published: (2015-06-01)

Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization
by: Jamal Mohd-Hafifi, et al.
Published: (2012-08-01)

International biological engagement programs facilitate Newcastle disease epidemiological studies
by: Patti J. Miller, et al.
Published: (2015-10-01)

Genetic Diversity of Newcastle Disease Virus Involved in the 2021 Outbreaks in Backyard Poultry Farms in Tanzania
by: Charlie F. Amoia, et al.
Published: (2023-07-01)

Multi-epitope peptide vaccine prediction against Newcastle disease virus using immuno-informatics approaches
by: N. Putri, et al.
Published: (2021-03-01)

The production of Newcastle disease virus-like particles in Nicotiana benthamiana as potential vaccines
by: Tanja Smith, et al.
Published: (2023-02-01)

Exploration of the Delivery of Oncolytic Newcastle Disease Virus by Gelatin Methacryloyl Microneedles
by: Qiang Zhang, et al.
Published: (2024-02-01)

Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
by: Robin Park, et al.
Published: (2020-08-01)

The 3D8 single chain variable fragment protein suppresses Newcastle disease virus transmission in transgenic chickens
by: Sung June Byun, et al.
Published: (2020-08-01)

Green synthesis of oncolytic Newcastle disease virus-loaded thiolated chitosan nanoformulation for CD44 targeted delivery and sustained release of virus in cervical cancer xenografts
by: Kousain Kousar, et al.
Published: (2023-08-01)

Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation
by: Kotaro Sugawara, et al.
Published: (2021-09-01)

Newcastle disease virus vaccine strains: immunogenicity is not influenced by ICPI
by: MA Orsi, et al.
Published: (2009-06-01)

Screening and mechanistic study of key sites of the hemagglutinin-neuraminidase protein related to the virulence of Newcastle disease virus
by: Chuanqi Yan, et al.
Published: (2020-07-01)

Multiple potential recombination events among Newcastle disease virus genomes in China between 1946 and 2020
by: Amina Nawal Bahoussi, et al.
Published: (2023-05-01)

Evaluation of the in vitro and in vivo effect of liposomal doxorubicin along with oncolytic Newcastle disease virus on 4T1 cell line: Animal preclinical research
by: Pooya Faranoush, et al.
Published: (2023-05-01)

Adaptor complex-mediated trafficking of Newcastle disease virus fusion protein is regulated by the YLMY motif of its cytoplasmic tail
by: Yawen Bu, et al.
Published: (2022-12-01)

Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
by: Fang Huang, et al.
Published: (2022-07-01)

Intratumoral Virotherapy with Wild-Type Newcastle Disease Virus in Carcinoma Krebs-2 Cancer Model
by: Kseniya S. Yurchenko, et al.
Published: (2021-03-01)

Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?
by: Paulina Mertowska, et al.
Published: (2023-09-01)

Spray vaccination against Newcastle disease: efficacy of Newcastle disease V4 vaccine
by: Ibrahim, A. Latif
Published: (1979)

PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma
by: David J. Pinato, et al.
Published: (2021-03-01)

Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer
by: Hui LI, et al.
Published: (2017-11-01)